Travere Therapeutics
TVTX
TVTX
147 hedge funds and large institutions have $1.48B invested in Travere Therapeutics in 2021 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 43 increasing their positions, 53 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
147
Holders Change
+12
Holders Change %
+8.89%
% of All Funds
2.58%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.07%
New
34
Increased
43
Reduced
53
Closed
21
Calls
$6.19M
Puts
$5.08M
Net Calls
+$1.11M
Net Calls Change
+$676K
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$44.9M |
| 2 |
VA
VR Adviser
New York
|
+$42M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$18.9M |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$10.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.75M |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$45.9M |
| 2 |
Goldman Sachs
New York
|
-$33.1M |
| 3 |
AC
Armistice Capital
New York
|
-$24.3M |
| 4 |
D.E. Shaw & Co
New York
|
-$19.2M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$17.4M |
